Alopecia Areata After Dupilumab for Atopic Dermatitis
March 2018
in “
JAAD case reports
”
TLDR Dupilumab for eczema may cause hair loss.
Dupilumab, a biologic therapy approved for atopic dermatitis (AD), was generally considered safe based on over 1,000 adult patient exposures, with conjunctivitis being the most notable side effect. However, a case was reported where a patient developed alopecia areata (AA) within 5 weeks of starting dupilumab treatment for AD, highlighting a potential adverse effect not previously emphasized.
View this study on jaadcasereports.org →
Cited in this study
1 / results
research The Changing Landscape of Alopecia Areata: The Therapeutic Paradigm
New treatments for Alopecia Areata, like JAK inhibitors, show promise for hair regrowth and are likely to change future treatment approaches.